Geoffrey Shapiro, M.D., Ph.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Geoffrey Shapiro, M.D., Ph.D., Dana-Farber Cancer Institute

Caption

Geoffrey Shapiro, M.D., Ph.D., is co-senior author of a New England Journal of Medicine report on a new oral drug that was effective in treating a rare, aggressive sarcoma.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.